- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Anthrax Vaccines will have significant change from previous year. By the most conservative estimates of global Anthrax Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 574 million in 2019. Over the next five years the Anthrax Vaccines market will register a 7.9% CAGR in terms of revenue, the global market size will reach US$ 777.6 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Live Vaccines
Cell free PA Vaccines
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Human Use
Animal Use
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anthrax Vaccines Consumption 2016-2026
2.1.2 Anthrax Vaccines Consumption CAGR by Region
2.2 Anthrax Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell free PA Vaccines
2.3 Anthrax Vaccines Sales by Type
2.3.1 Global Anthrax Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anthrax Vaccines Sale Price by Type (2016-2021)
2.4 Anthrax Vaccines Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Anthrax Vaccines Sales by Application
2.5.1 Global Anthrax Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global Anthrax Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anthrax Vaccines Sale Price by Application (2016-2021)
3 Global Anthrax Vaccines by Company
3.1 Global Anthrax Vaccines Sales Market Share by Company
3.1.1 Global Anthrax Vaccines Sales by Company (2019-2021)
3.1.2 Global Anthrax Vaccines Sales Market Share by Company (2019-2021)
3.2 Global Anthrax Vaccines Revenue Market Share by Company
3.2.1 Global Anthrax Vaccines Revenue by Company (2019-2021)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global Anthrax Vaccines Sale Price by Company
3.4 Global Manufacturers Anthrax Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anthrax Vaccines Product Location Distribution
3.4.2 Players Anthrax Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Anthrax Vaccines by Region
4.1 Global Anthrax Vaccines by Region
4.1.1 Global Anthrax Vaccines Sales by Region
4.1.2 Global Anthrax Vaccines Revenue by Region
4.2 Americas Anthrax Vaccines Sales Growth
4.3 APAC Anthrax Vaccines Sales Growth
4.4 Europe Anthrax Vaccines Sales Growth
4.5 Middle East & Africa Anthrax Vaccines Sales Growth
5 Americas
5.1 Americas Anthrax Vaccines Sales by Country
5.1.1 Americas Anthrax Vaccines Sales by Country (2016-2021)
5.1.2 Americas Anthrax Vaccines Revenue by Country (2016-2021)
5.2 Americas Anthrax Vaccines Sales by Type
5.3 Americas Anthrax Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anthrax Vaccines Sales by Region
6.1.1 APAC Anthrax Vaccines Sales by Region (2016-2021)
6.1.2 APAC Anthrax Vaccines Revenue by Region (2016-2021)
6.2 APAC Anthrax Vaccines Sales by Type
6.3 APAC Anthrax Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anthrax Vaccines by Country
7.1.1 Europe Anthrax Vaccines Sales by Country (2016-2021)
7.1.2 Europe Anthrax Vaccines Revenue by Country (2016-2021)
7.2 Europe Anthrax Vaccines Sales by Type
7.3 Europe Anthrax Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anthrax Vaccines by Country
8.1.1 Middle East & Africa Anthrax Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anthrax Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa Anthrax Vaccines Sales by Type
8.3 Middle East & Africa Anthrax Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anthrax Vaccines Distributors
10.3 Anthrax Vaccines Customer
11 Global Anthrax Vaccines Market Forecast
11.1 Global Anthrax Vaccines Forecast by Region
11.1.1 Global Anthrax Vaccines Forecast by Regions (2021-2026)
11.2.2 Global Anthrax Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Anthrax Vaccines Forecast by Type
11.7 Global Anthrax Vaccines Forecast by Application
12 Key Players Analysis
12.1 Emergent BioSolutions
12.1.1 Emergent BioSolutions Emergent BioSolutions Company Information
12.1.2 Emergent BioSolutions Anthrax Vaccines Product Offered
12.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Emergent BioSolutions Main Business Overview
12.1.5 Emergent BioSolutions Latest Developments
12.2 Merial
12.2.1 Merial Company Information
12.2.2 Merial Anthrax Vaccines Product Offered
12.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merial Main Business Overview
12.2.5 Merial Latest Developments
12.3 Merck
12.3.1 Merck Company Information
12.3.2 Merck Anthrax Vaccines Product Offered
12.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Merck Main Business Overview
12.3.5 Merck Latest Developments
12.4 Zoetis
12.4.1 Zoetis Company Information
12.4.2 Zoetis Anthrax Vaccines Product Offered
12.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Zoetis Main Business Overview
12.4.5 Zoetis Latest Developments
12.5 Bayer Sanidad Animal
12.5.1 Bayer Sanidad Animal Company Information
12.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Offered
12.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Bayer Sanidad Animal Main Business Overview
12.5.5 Bayer Sanidad Animal Latest Developments
12.6 Colorado Serum
12.6.1 Colorado Serum Company Information
12.6.2 Colorado Serum Anthrax Vaccines Product Offered
12.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Colorado Serum Main Business Overview
12.6.5 Colorado Serum Latest Developments
12.7 PharmAthene
12.7.1 PharmAthene Company Information
12.7.2 PharmAthene Anthrax Vaccines Product Offered
12.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 PharmAthene Main Business Overview
12.7.5 PharmAthene Latest Developments
12.8 Tiankang
12.8.1 Tiankang Company Information
12.8.2 Tiankang Anthrax Vaccines Product Offered
12.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Tiankang Main Business Overview
12.8.5 Tiankang Latest Developments
12.9 Biogénesis-Bago
12.9.1 Biogénesis-Bago Company Information
12.9.2 Biogénesis-Bago Anthrax Vaccines Product Offered
12.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Biogénesis-Bago Main Business Overview
12.9.5 Biogénesis-Bago Latest Developments
12.10 CAVAC
12.10.1 CAVAC Company Information
12.10.2 CAVAC Anthrax Vaccines Product Offered
12.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 CAVAC Main Business Overview
12.10.5 CAVAC Latest Developments
12.11 Rosenbusch
12.11.1 Rosenbusch Company Information
12.11.2 Rosenbusch Anthrax Vaccines Product Offered
12.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Rosenbusch Main Business Overview
12.11.5 Rosenbusch Latest Developments
12.12 Agrovet
12.12.1 Agrovet Company Information
12.12.2 Agrovet Anthrax Vaccines Product Offered
12.12.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Agrovet Main Business Overview
12.12.5 Agrovet Latest Developments
12.13 Vecol
12.13.1 Vecol Company Information
12.13.2 Vecol Anthrax Vaccines Product Offered
12.13.3 Vecol Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Vecol Main Business Overview
12.13.5 Vecol Latest Developments
12.14 CVCRI
12.14.1 CVCRI Company Information
12.14.2 CVCRI Anthrax Vaccines Product Offered
12.14.3 CVCRI Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 CVCRI Main Business Overview
12.14.5 CVCRI Latest Developments
12.15 IVPM
12.15.1 IVPM Company Information
12.15.2 IVPM Anthrax Vaccines Product Offered
12.15.3 IVPM Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 IVPM Main Business Overview
12.15.5 IVPM Latest Developments
12.16 Prondil
12.16.1 Prondil Company Information
12.16.2 Prondil Anthrax Vaccines Product Offered
12.16.3 Prondil Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Prondil Main Business Overview
12.16.5 Prondil Latest Developments
12.17 CDV
12.17.1 CDV Company Information
12.17.2 CDV Anthrax Vaccines Product Offered
12.17.3 CDV Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 CDV Main Business Overview
12.17.5 CDV Latest Developments
12.18 Indian Immunologicals
12.18.1 Indian Immunologicals Company Information
12.18.2 Indian Immunologicals Anthrax Vaccines Product Offered
12.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Indian Immunologicals Main Business Overview
12.18.5 Indian Immunologicals Latest Developments
12.19 Botswana Vaccine Institute
12.19.1 Botswana Vaccine Institute Company Information
12.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Offered
12.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Botswana Vaccine Institute Main Business Overview
12.19.5 Botswana Vaccine Institute Latest Developments
12.20 Ceva Santé Animale
12.20.1 Ceva Santé Animale Company Information
12.20.2 Ceva Santé Animale Anthrax Vaccines Product Offered
12.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Ceva Santé Animale Main Business Overview
12.20.5 Ceva Santé Animale Latest Developments
12.21 Intervac
12.21.1 Intervac Company Information
12.21.2 Intervac Anthrax Vaccines Product Offered
12.21.3 Intervac Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Intervac Main Business Overview
12.21.5 Intervac Latest Developments
12.22 JOVAC
12.22.1 JOVAC Company Information
12.22.2 JOVAC Anthrax Vaccines Product Offered
12.22.3 JOVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 JOVAC Main Business Overview
12.22.5 JOVAC Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Anthrax Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Live Vaccines
Table 3. Major Players of Cell free PA Vaccines
Table 4. Global Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 5. Global Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 6. Global Anthrax Vaccines Revenue by Type (2016-2021) & ($ million)
Table 7. Global Anthrax Vaccines Revenue Market Share by Type (2016-2021)
Table 8. Global Anthrax Vaccines Sale Price by Type (2016-2021)
Table 9. Global Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 10. Global Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 11. Global Anthrax Vaccines Value by Application (2016-2021)
Table 12. Global Anthrax Vaccines Revenue Market Share by Application (2016-2021)
Table 13. Global Anthrax Vaccines Sale Price by Application (2016-2021)
Table 14. Global Anthrax Vaccines Sales by Company (2019-2021) & (M Doses)
Table 15. Global Anthrax Vaccines Sales Market Share by Company (2019-2021)
Table 16. Global Anthrax Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Anthrax Vaccines Revenue Market Share by Company (2019-2021)
Table 18. Global Anthrax Vaccines Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Anthrax Vaccines Producing Area Distribution and Sales Area
Table 20. Players Anthrax Vaccines Products Offered
Table 21. Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Anthrax Vaccines Sales by Region (2016-2021) (M Doses)
Table 25. Global Anthrax Vaccines Sales Market Share by Region (2016-2021)
Table 26. Global Anthrax Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Anthrax Vaccines Revenue Market Share by Region (2016-2021)
Table 28. Americas Anthrax Vaccines Sales by Country (2016-2021) & (M Doses)
Table 29. Americas Anthrax Vaccines Sales Market Share by Country (2016-2021)
Table 30. Americas Anthrax Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Anthrax Vaccines Revenue Market Share by Country (2016-2021)
Table 32. Americas Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 33. Americas Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 34. Americas Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 35. Americas Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 36. APAC Anthrax Vaccines Sales by Region (2016-2021) & (M Doses)
Table 37. APAC Anthrax Vaccines Sales Market Share by Region (2016-2021)
Table 38. APAC Anthrax Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Anthrax Vaccines Revenue Market Share by Region (2016-2021)
Table 40. APAC Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 41. APAC Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 42. APAC Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 43. APAC Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 44. Europe Anthrax Vaccines Sales by Country (2016-2021) & (M Doses)
Table 45. Europe Anthrax Vaccines Sales Market Share by Country (2016-2021)
Table 46. Europe Anthrax Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Anthrax Vaccines Revenue Market Share by Country (2016-2021)
Table 48. Europe Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 49. Europe Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 50. Europe Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 51. Europe Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Anthrax Vaccines Sales by Country (2016-2021) & (M Doses)
Table 53. Middle East & Africa Anthrax Vaccines Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Anthrax Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Anthrax Vaccines Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Anthrax Vaccines Sales by Type (2016-2021) & (M Doses)
Table 57. Middle East & Africa Anthrax Vaccines Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Anthrax Vaccines Sales by Application (2016-2021) & (M Doses)
Table 59. Middle East & Africa Anthrax Vaccines Sales Market Share by Application (2016-2021)
Table 60. Global Anthrax Vaccines Sales Forecast by Type (2021-2026) & (M Doses)
Table 61. Global Anthrax Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Anthrax Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Anthrax Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Anthrax Vaccines Sales Forecast by Application (2021-2026) & (M Doses)
Table 65. Global Anthrax Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Anthrax Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Anthrax Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 68. Emergent BioSolutions Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 69. Emergent BioSolutions Anthrax Vaccines Product Offered
Table 70. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 71. Emergent BioSolutions Main Business
Table 72. Emergent BioSolutions Latest Developments
Table 73. Merial Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merial Anthrax Vaccines Product Offered
Table 75. Merial Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 76. Merial Main Business
Table 77. Merial Latest Developments
Table 78. Merck Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Anthrax Vaccines Product Offered
Table 80. Merck Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Zoetis Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Zoetis Anthrax Vaccines Product Offered
Table 85. Zoetis Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 86. Zoetis Main Business
Table 87. Zoetis Latest Developments
Table 88. Bayer Sanidad Animal Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Bayer Sanidad Animal Anthrax Vaccines Product Offered
Table 90. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 91. Bayer Sanidad Animal Main Business
Table 92. Bayer Sanidad Animal Latest Developments
Table 93. Colorado Serum Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Colorado Serum Anthrax Vaccines Product Offered
Table 95. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 96. Colorado Serum Main Business
Table 97. Colorado Serum Latest Developments
Table 98. PharmAthene Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. PharmAthene Anthrax Vaccines Product Offered
Table 100. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 101. PharmAthene Main Business
Table 102. PharmAthene Latest Developments
Table 103. Tiankang Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Tiankang Anthrax Vaccines Product Offered
Table 105. Tiankang Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 106. Tiankang Main Business
Table 107. Tiankang Latest Developments
Table 108. Biogénesis-Bago Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Biogénesis-Bago Anthrax Vaccines Product Offered
Table 110. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 111. Biogénesis-Bago Main Business
Table 112. Biogénesis-Bago Latest Developments
Table 113. CAVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. CAVAC Anthrax Vaccines Product Offered
Table 115. CAVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 116. CAVAC Main Business
Table 117. CAVAC Latest Developments
Table 118. Rosenbusch Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Rosenbusch Anthrax Vaccines Product Offered
Table 120. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 121. Rosenbusch Main Business
Table 122. Rosenbusch Latest Developments
Table 123. Agrovet Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Agrovet Anthrax Vaccines Product Offered
Table 125. Agrovet Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 126. Agrovet Main Business
Table 127. Agrovet Latest Developments
Table 128. Vecol Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Vecol Anthrax Vaccines Product Offered
Table 130. Vecol Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 131. Vecol Main Business
Table 132. Vecol Latest Developments
Table 133. CVCRI Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. CVCRI Anthrax Vaccines Product Offered
Table 135. CVCRI Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 136. CVCRI Main Business
Table 137. CVCRI Latest Developments
Table 138. IVPM Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. IVPM Anthrax Vaccines Product Offered
Table 140. IVPM Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 141. IVPM Main Business
Table 142. IVPM Latest Developments
Table 143. Prondil Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Prondil Anthrax Vaccines Product Offered
Table 145. Prondil Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 146. Prondil Main Business
Table 147. Prondil Latest Developments
Table 148. CDV Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. CDV Anthrax Vaccines Product Offered
Table 150. CDV Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 151. CDV Main Business
Table 152. CDV Latest Developments
Table 153. Indian Immunologicals Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Indian Immunologicals Anthrax Vaccines Product Offered
Table 155. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 156. Indian Immunologicals Main Business
Table 157. Indian Immunologicals Latest Developments
Table 158. Botswana Vaccine Institute Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Botswana Vaccine Institute Anthrax Vaccines Product Offered
Table 160. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 161. Botswana Vaccine Institute Main Business
Table 162. Botswana Vaccine Institute Latest Developments
Table 163. Ceva Santé Animale Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Ceva Santé Animale Anthrax Vaccines Product Offered
Table 165. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 166. Ceva Santé Animale Main Business
Table 167. Ceva Santé Animale Latest Developments
Table 168. Intervac Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Intervac Anthrax Vaccines Product Offered
Table 170. Intervac Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 171. Intervac Main Business
Table 172. Intervac Latest Developments
Table 173. JOVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. JOVAC Anthrax Vaccines Product Offered
Table 175. JOVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 176. JOVAC Main Business
Table 177. JOVAC Latest Developments
List of Figures
Figure 1. Picture of Anthrax Vaccines
Figure 2. Anthrax Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anthrax Vaccines Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global Anthrax Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anthrax Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Cell free PA Vaccines
Figure 11. Global Anthrax Vaccines Sales Market Share by Type in 2020
Figure 12. Global Anthrax Vaccines Revenue Market Share by Type (2016-2021)
Figure 13. Anthrax Vaccines Consumed in Human Use
Figure 14. Global Anthrax Vaccines Market: Human Use (2016-2021) & (M Doses)
Figure 15. Anthrax Vaccines Consumed in Animal Use
Figure 16. Global Anthrax Vaccines Market: Animal Use (2016-2021) & (M Doses)
Figure 17. Global Anthrax Vaccines Sales Market Share by Application (2016-2021)
Figure 18. Global Anthrax Vaccines Revenue Market Share by Application in 2020
Figure 19. Global Anthrax Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Anthrax Vaccines Revenue Market Share by Company in 2020
Figure 21. Global Anthrax Vaccines Sales Market Share by Regions (2016-2021)
Figure 22. Global Anthrax Vaccines Revenue Market Share by Region in 2020
Figure 23. Americas Anthrax Vaccines Sales 2016-2021 (M Doses)
Figure 24. Americas Anthrax Vaccines Revenue 2016-2021 ($ Millions)
Figure 25. APAC Anthrax Vaccines Sales 2016-2021 (M Doses)
Figure 26. APAC Anthrax Vaccines Revenue 2016-2021 ($ Millions)
Figure 27. Europe Anthrax Vaccines Sales 2016-2021 (M Doses)
Figure 28. Europe Anthrax Vaccines Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Anthrax Vaccines Sales 2016-2021 (M Doses)
Figure 30. Middle East & Africa Anthrax Vaccines Revenue 2016-2021 ($ Millions)
Figure 31. Americas Anthrax Vaccines Sales Market Share by Country in 2020
Figure 32. Americas Anthrax Vaccines Revenue Market Share by Country in 2020
Figure 33. Americas Anthrax Vaccines Sales Market Share by Type in 2020
Figure 34. Americas Anthrax Vaccines Sales Market Share by Application in 2020
Figure 35. United States Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Anthrax Vaccines Sales Market Share by Region in 2020
Figure 40. APAC Anthrax Vaccines Revenue Market Share by Regions in 2020
Figure 41. APAC Anthrax Vaccines Sales Market Share by Type in 2020
Figure 42. APAC Anthrax Vaccines Sales Market Share by Application in 2020
Figure 43. China Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Anthrax Vaccines Sales Market Share by Country in 2020
Figure 50. Europe Anthrax Vaccines Revenue Market Share by Country in 2020
Figure 51. Europe Anthrax Vaccines Sales Market Share by Type in 2020
Figure 52. Europe Anthrax Vaccines Sales Market Share by Application in 2020
Figure 53. Germany Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Anthrax Vaccines Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Anthrax Vaccines Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Anthrax Vaccines Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Anthrax Vaccines Sales Market Share by Application in 2020
Figure 62. Egypt Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Anthrax Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
